AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.
| 1.814 | |
| 1.814 | |
| - | |
| 1.814 | |
| 1.814 | |
| 0.082-4 | |
| 235 M | |
| 129 M | |
| 50 697 K | |
| -0.048 | |
| 1.535 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Key Insights Institutions' substantial holdings in AVITA Medical implies that they have significant influence over the company's share price The top 25 shareholders own 49% of the company Recent purc...
AVITA Medical VALENCIA, Calif., Jan. 10, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a commercial-stage regenerative medicine company focused on first-i...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
